EPT Disclosure

12 Jun 2006 11:34

Deutsche Bank AG London12 June 2006 FORM 38.5(a) DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY (Rule 38.5(a) of the Takeover Code) 1. KEY INFORMATION Name of exempt principal trader Deutsche Bank AG London Company dealt in Cambridge Antibody Technology Group Plc Class of relevant security to which the Ordinarydealings being disclosed relate (Note 1) Date of dealing 09/06/2006 2. DEALINGS (Note 2) (a) Purchases and sales Total number of securities purchased Highest price paid (Note 3) Lowest price paid (Note 3) 5,508 £13.105 £13.0659 Total number of securities sold Highest price received (Note 3) Lowest price received (Note 3) 9,016 £13.085 £13.0659 (b) Derivatives transactions (other than options) Product name, Long/short (Note 4) Number of securities (Note 5) Price per unit (Note 3)e.g. CFD CFD Short 4,508 £13.066 (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product name, Writing, selling, Number of securities Exercise Type, e.g. Expiry Option money purchasing, to which the option American,e.g. call option varying etc. relates (Note 5) price European etc. Date paid/received per unit (Note 3) (ii) Exercising Product name, e.g. call option Number of securities Exercise price per unit (Note 3) 3. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relatingto the voting rights of any relevant securities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form isreferenced. If none, this should be stated. NONE Date of disclosure 12/06/2006 Contact name Kelly-Jade Ledwich Telephone number 020 7545 7804 Name of offeree/offeror with which connected AstraZeneca PlcNature of connection (Note 6) Adviser to the offeror Notes The Notes on Form 38.5(a) can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk This information is provided by RNS The company news service from the London Stock Exchange